Clinical Trial Update: GALLANT 6 Tesaglitazar vs. Pioglitazone [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Tesaglitazar to Pioglitazone for Type 2 diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Tesaglitazar (tesaglitazar)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED